Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial

Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T02:47:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-26T03:58:31.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T05:26:58.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T03:22:06.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The Revision label on the page updated from v3.6.6 to v3.7.0. This reflects a platform version update for the Record History view.
    Difference
    0.1%
    Check dated 2026-09-21T00:42:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, was added to the record history, replacing Revision: v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T22:19:02.000Z thumbnail image

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.